meiragtx.com - MGTX Aggregate Business Value

Graphic logo of MeiraGTx Corp (MGTX)

This daily price chart for MeiraGTx Holdings plc (MGTX) shows a value of 880.81. MeiraGTx Holdings plc (MGTX) adheres to environmental standards through laboratory energy efficiency and chemical waste disposal. The business relies on significant pricing power in gene therapy, utilizing innovative riboswitches to control drug dosing. Project development is based on strategic alliances with global pharmaceutical leaders to combat rare pathologies.

MeiraGTx Corp (MGTX) - Enterprise Value from 11/23/2025 to 11/01/2026
Flagship merchandise of MeiraGTx Holdings plc

This metric is calculated as the sum of the company's market capitalization and net debt. This figure determines the actual cost of a full business buyout, accounting for all liabilities. For MeiraGTx Holdings plc (MGTX), such investments are directed toward the development of robotic lines for gene vector synthesis. When assessing enterprise value, it is critical to distinguish asset capitalization from an increase in debt load. The price action of this enterprise value reflects the company's real market price.

Who MeiraGTx Holdings plc competes with

Full Takeover Company Value Tempus AI|QGEN: Real Price to Acquire Entire Company|Isis Pharmaceuticals - Aggregate Business Value|RGEN (Repligen Corporation) - Real Price to Acquire Entire Company|Business Value RNA|CRSP (CRISPR Therapeutics) - Enterprise Value|Business Value WGS (GeneDx Holdings)|Total Company Value Ultragenyx Pharma (RARE)|Beam Tx - Business Value|Enterprise Value SRPT (Sarepta Therapeutics, Inc.)|Enterprise Value twistbioscience.com TWST|TXG - Total Company Value|Intellia Therapeutics Inc (NTLA) - Real Price to Acquire Entire Company|STOK: Enterprise Value|Total Enterprise Value BioLife (BLFS)|WVE (Wave Life Sciences) - Enterprise Value|mazetx.com (MAZE) - Company Buyout Price|Total Company Value Sionna Therapeutics (SION)|PRME (Prime Medicine Inc) - Value Adjusted for Debt and Cash|Enterprise Value TSHA (Taysha)|Enterprise Value uniQure Pharma QURE|REGENXBIO Inc. - Enterprise Value|Full Takeover Company Value solidbio.com (SLDB)|OCGN (Ocugen) - Real Price to Acquire Entire Company|PACB: Aggregate Business Value|Real Price to Acquire Entire Company BNTC|Business Value DSGN (Design Corp)|Real Price to Acquire Entire Company RCKT (Rocket Pharmaceuticals)|FDMT (4dmoleculartherapeutics.com) - Value Adjusted for Debt and Cash|Enterprise Value LXEO (Lexeo Therapeutics, Inc.)|Value Adjusted for Debt and Cash KRRO|EDIT - Total Company Value|Total Enterprise Value Silence Therapeutics Corp|proqr.com (PRQR) - Total Company Value|CDXS (Codexis) - Total Company Value|SGMO (Sangamo Therapeutics, Inc.) - Enterprise Value|Business Value NAUT (Nautilus Biotechnology Inc)|Enterprise Value MGX|Company Buyout Price precisionbiosciences.com|Total Company Value Generation Bio GBIO|BOLD: Business Value|Exicure Corp - Enterprise Value|Full Takeover Company Value Imunon, Inc. (IMNN)|phiopharma.com (PHIO) - Total Company Value|MBIO - Company Buyout Price|Real Price to Acquire Entire Company RNAZ|BNGO: Value Adjusted for Debt and Cash|Total Company Value Applied DNA Sciences, Inc. (APDN)|BLUE: Full Business Value|Total Company Value ImmunoPrecise Antibodies Ltd. IPA|Omega Therapeutics Corp - Total Company Value|Singular Genomics Systems - Enterprise Value|regulusrx.com (RGLS) - Real Price to Acquire Entire Company|Syros Pharmaceuticals, Inc. (SYRS) - Total Company Value|Real Price to Acquire Entire Company Telesis Bio Inc.|TCON (TRACON) - Enterprise Value|UBX - Full Takeover Company Value